Table 4.
Feature | Cluster 1 (n = 9) | Cluster 2 (n = 8) | Cluster 3 (n = 9) | P |
---|---|---|---|---|
Gender (male %) | 56% | 38% | 67% | 0.547 |
Age at onset (y) | 13.6 (±3.55) | 12.6 (±8.1) | 11.6 (±5.72) | 0.777 |
Serum C3 (mg/dl) | 27 (±16.8) | 22.2 (±17.2) | 20.9 (±18) | 0.739 |
Plasma sC5b9 (ng/ml) | 1800 (±1150)* | 1820 (±1210)* | 296 (±118) | 0.003 |
u-Protein (g/24h) | 3.3 (±3.1) | 5.7 (±4.9) | 1.7 (±1.9) | 0.099 |
s-Creatinine (mg/dl) | 0.68 (±0.18) | 0.71 (±0.19) | 0.59 (±0.26) | 0.426 |
C3 at IF | 2.94 (±0.17) | 2.94 (±0.18) | 2.72 (±0.36) | 0.137 |
IgG at IF | 0.67 (±1.12) | 2.50 (±0.54)° | 0.28 (±0.44) | 9.6E-06 |
C1q at IF | 0.50 (±0.71) | 1.50 (±0.89)° | 0.278 (±0.44) | 0.003 |
Mesangial deposits at EM | 67% | 38% | 56% | 0.547 |
Subepithelial deposits at EM | 78%* | 38% | 11% | 0.016 |
Subendothelial deposits at EM | 100%* | 100%* | 0% | 6.4E-07 |
Intramembr. highly dense deposits at EM | 11% | 0% | 100%# | 6.4E-06 |
EM, electron microscopy; u-protein, proteinuria; s-Creatinine, serum creatinine.
Data are expressed as mean ± SD or as % of positive patients.
Significantly different vs. cluster 3.
Significantly different vs. clusters 1 and 3.
Significantly different vs. clusters 1 and 2.
Bold characters indicate statistically significant values.